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Evidence is now emerging that early life environment can have lifelong effects on metabolic, cardiovascular, and
pulmonary function in offspring, a concept also known as fetal or developmental programming. In mammals,
developmental programming is thought to occur mainly via epigenetic mechanisms, which include DNA methylation,
histone modifications, and expression of non-coding RNAs. The effects of developmental programming can be induced
by the intrauterine environment, leading to intergenerational epigenetic effects from one generation to the next.
Transgenerational epigenetic inheritance may be considered when developmental programming is transmitted
across generations that were not exposed to the initial environment which triggered the change. So far, inter- and
transgenerational programming has been mainly described for cardiovascular and metabolic disease risk. In this
review, we discuss available evidence that epigenetic inheritance also occurs in respiratory diseases, using asthma
and chronic obstructive pulmonary disease (COPD) as examples. While multiple epidemiological as well as animal
studies demonstrate effects of ‘toxic’ intrauterine exposure on various asthma-related phenotypes in the offspring,
only few studies link epigenetic marks to the observed phenotypes. As epigenetic marks may distinguish individuals
most at risk of later disease at early age, it will enable early intervention strategies to reduce such risks. To achieve this
goal further, well designed experimental and human studies are needed.
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Introduction
Asthma and chronic obstructive pulmonary disease
(COPD) are chronic lung diseases, both thought to re-
sult from a complex interplay of genetic factors and
environmental exposures. These gene-environment in-
teractions, in general, are now known to be mediated
by epigenetic mechanisms such as histone modifica-
tions [1], DNA methylation [2] and hydroxyl methyla-
tion [3], chromatin remodeling [4], and expression of
non-coding RNAs [5]. Epigenetic events are uniquely
susceptible to endogenous and exogenous factors and
most commonly take place during the prenatal period
as the epigenome plays a vital role in embryonic develop-
ment and tissue differentiation [6,7]. Epigenetic changes* Correspondence: m.n.hylkema@umcg.nl
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unless otherwise stated.are different from genetic changes as they do not involve
alterations of the DNA sequence and hence are, in
principle, reversible [8]. As they were found to be inherit-
able, epigenetic events can be long lasting and passed on
to the next generation. This is not limited to the first gen-
eration of the progeny but can involve the grandchildren
and even further generations [9]. Mechanisms on epigen-
etic inheritance have been extensively reviewed recently
[10-14] and will be discussed only briefly in this review.Definition of inter- and transgenerational inheritance
In this review, we describe evidence from epidemio-
logical and experimental studies for asthma and COPD
which suggest that epigenetic inheritance does occur.
However, epigenetic marks can only be retained and
transmitted from one generation to the next when re-
programming of the germ line fails to remove epigenetic
signatures that are required during development. The ef-
fects of developmental programming can be induced by
the intrauterine environment (cigarette smoke, nutrition,
and stress) which not only affect the fetus (F1) but alson Access article distributed under the terms of the Creative Commons
rg/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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generational epigenetic effects. When developmental
programming is transmitted across generations beyond
F3, it is considered to be transgenerational and can not
be explained by direct environmental exposure anymore.
Only a few studies provide evidence for transgenera-
tional epigenetic inheritance, which was mainly trans-
mitted down the paternal line [9].
Epigenetics in asthma
Asthma is a common chronic inflammatory disorder of
the airways, of which the prevalence has increased dra-
matically during the last two to three decades. Asthma is
characterized by recurring episodes of airflow obstruc-
tion, intermittent chest symptoms such as wheezing,
coughing, and shortness of breath, as well as bronchial
hyperresponsiveness (BHR) [15,16]. In the developed
world, approximately 50% of asthma patients suffer from
the allergic phenotype of disease [17] in which type 2
helper T cell (Th2) activation is dominant, resulting in
an increased level of Th2 cytokines, such as interleukin
(IL)-4, IL-5, and IL-13, a decreased level of Th1 cyto-
kines, such as interferon-gamma (IFN-γ), and an im-
paired function of regulatory T cells (Tregs).
Genetic sequence variations are associated with risk
for asthma [18-23] but are per se unable to explain the
escalating incidence of chronic inflammatory disorders
during the past decades. Over time, it became evident
that DNA variation can be associated with modified re-
sponses to environmental challenges [22]. However, gen-
etic variants can also affect epigenetic signatures through
differential DNA methylation of CPG sites [23,24]. Inter-
estingly, a three-way interaction of genetic variations,
DNA methylation and environmental exposure was first
demonstrated by Salam et al. [25], who showed that ex-
posure to particulate matter and methylation levels of the
NOS2 promoter haplotypes jointly influenced levels of ex-
haled nitric oxide. Thus, epigenetic mechanisms in inter-
action with genetic variants might confer further flexibility
towards environmental exposures.
Nonetheless, it remains an open question why envir-
onmental exposures interact with gene variations and
thereby possibly bear potential to modify disease risks
during critical developmental windows only. As outlined
in the introduction, it has been hypothesized that envir-
onmental influences during vulnerable developmental
periods may lead to lasting changes of the epigenome
resulting in altered functionality of the lung and/or the
immune system. So far, the majority of human studies
have looked at associations of epigenetic modifications -
for technical reasons mainly DNA methylation - with
respiratory disease.
For example, genome-wide DNA methylation was ana-
lyzed in isolated peripheral monocytes from adult patientswith eosinophilic, paucigranulocytic, or neutrophilic asthma
versus healthy controls. While nine genes (TBX5, RBP1,
NRG1, KCNQ4, PYY2, FAM19A4, SYNM, ME1, AK5)
were hypermethylated and common to all asthma pheno-
types, single in silico constructed networks were charac-
teristic for the different asthma phenotypes [26].
In addition, using candidate gene approaches, a num-
ber of genes related to asthma and involved in oxidative
stress, immunity, and lipid metabolism were investi-
gated. In an analysis of 12 genes implicated in oxidative
stress pathways, higher methylation of protocadherin-20
(PCDH-20) was observed in sputa from adult smokers
with asthma compared to non-asthmatic subjects with a
similar smoking history and without COPD [27]. Methyl-
ated paired box 5 protein transcription factor (PAX-5a),
although not being associated with asthma risk, inter-
acted synergistically with PCDH-20. In another study,
adrenergic-receptor beta-2 (ADRB2) 5′-UTR methyla-
tion was analyzed in whole blood from 60 children with
mild asthma and 122 children with severe asthma. Here,
higher methylation was positively related to severity of
asthma, in a dose-dependent manner [28]. In addition,
children with severe asthma and exposure to higher
levels of indoor NO2 correlated positively with ADBR2
methylation, indicating the latter may directly or indir-
ectly modify the effect of NO2 on asthma severity. This
observation was recently challenged by Gaffin et al. [29]
who reported an inverse relation between average CpG
methylation of ADBR2 with asthma severity in periph-
eral blood or saliva from 177 elementary school children
with physician-diagnosed asthma, enrolled in the School
Inner-City Asthma Study. The participants of both studies
were of comparable age and similar diagnostic criteria for
asthma were applied; however, as also emphasized by the
authors, different regions of the ADRB2 gene were ana-
lyzed. This highlights the necessity to ensure that altered
methylation affects gene expression and function and is
not an epiphenomenon.
In this line, differential methylation of FOXP3 and
IFNγ promoter regions was demonstrated in isolated
peripheral regulatory and effector T cells from 21 mono-
zygotic twin pairs discordant for asthma (age range 9 to
76 years). Higher methylation of both genes was associ-
ated with reduced mRNA and protein levels and was
further associated with reduced suppressor function and
T cell proliferation. Interestingly, FOXP3 levels were
lowest in asthmatic twins who were additionally exposed
to passive smoking. Moreover, increased methylation of
FOXP3 was confirmed in purified bronchoalveolar lav-
age fluid (BALF) Tregs obtained from a subset of twins
[30]. This indicates that relevant epigenetic changes of
immune cells may also be seen in the periphery which
would facilitate investigations in humans. On the other
hand, Stefanowiscz et al. emphasized the importance of
Krauss-Etschmann et al. Clinical Epigenetics  (2015) 7:53 Page 3 of 13addressing epigenetic changes in relevant target tissues
[31] while DNA methylation of STAT5A and CRIP1 in
airway epithelial cells distinguished asthmatic children
from non-asthmatic atopics and healthy controls, these
differences were not observed in PBMC. Similarly, cell-
specific DNA methylation at the A disintegrin and
metalloprotease 33 (ADAM33) gene promoter, which
has been implicated in severe asthma, differed consider-
ably between epithelial cells and fibroblasts and resulted
in altered gene regulation [32].
In peripheral B cells, the promoter region of prostaglan-
din D2 (PGD2) - an arachidonic acid-derived metabolite
supporting Th2 cell differentiation and eosinophilia -
was found to be hypomethylated from children with
physician-diagnosed asthma compared to healthy con-
trols [24]. Of note, the authors showed that hypomethy-
lation was a) related to DNA variants and b) confirmed
that this resulted in higher PGD2 expression levels sup-
porting the functional relevance of these epigenetic
changes.
Studies on epigenetics in asthma may have been ham-
pered, as over the years, different clinical subgroups have
been described. Hierarchical cluster analysis has demon-
strated that there are at least five phenotypes which seg-
regate according to age of onset, atopy, pulmonary
function, requirement for medications, and a number of
other factors [33]. However, in most published studies,
rigorous phenotyping of patients is lacking.
Epigenetics in COPD
COPD is a life-threatening lung disease, mainly caused
by cigarette smoking although other inhaled noxious
particles and gases may contribute [34]. This leads to
chronic airway inflammation, airway remodeling, and
emphysema of the lung parenchyma. These lung path-
ologies lead to obstruction of lung airflow that interferes
with normal breathing and is not fully reversible upon
treatment [35]. Also for COPD, the evidence of epigenetic
changes is emerging. Epigenetic modifications in bronchial
epithelium and sputum have been linked to health status
in patients with COPD [36,37] and cigarette smoking
[38,39]. In addition, epigenetic regulation was found to
be critically important in chronic remodeling [40], as
well as in small airway pathology. In small airway epi-
thelial cells (SAE) of nine ex-smoking patients with
COPD, hundreds of genes were found predominately
hypermethylated relative to SAE of ex-smoking individ-
uals without COPD, which was associated with lower
lung function [41]. Furthermore, as reviewed in [42],
the expression of the different epigenetic patterns in
various muscles of patients with COPD was found to
explain skeletal muscle dysfunction, a possible systemic
manifestation of this lung disease, especially in advanced
stages of COPD.Additionally, an epigenome-wide analysis in peripheral
blood cells demonstrated a large number of differentially
methylated genes, including the aryl hydrocarbon recep-
tor repressor (AHRR) [43], which was confirmed to-
gether with F2RL3 later in an independent study [44].
Of note, differential methylation of the AHRR was also
found in cord blood from children after prenatal smoke
exposure [45] (see below) and was shown to persist until
early infancy [46], demonstrating that there is at least in
some instances a prolonged epigenetic memory of envir-
onmental insults.
Temporal changes of DNA methylation
Although the examples above illustrate that epigenetic
changes occur in asthma and COPD, they bear the risk
of reverse causation as epigenetic modifications are in-
ducible and may represent a response to the pathology
rather than being its root. Therefore, temporal changes
of epigenetic marks as well as the timing of exposure
and outcome need to be investigated during the life
course. Temporal persistence of epigenetic DNA modifi-
cations were observed in adults after extended periods
of smoking cessation in adults, which may explain the
prolonged health risks after cigarette smoking. Thus, dif-
ferential methylation of F2RL3 and GPR15 was shown to
be significantly associated not only with current smoking
but also with time since quitting smoking, in a dose-
response relationship [47]. Similarly, Tsaprouni et al.
reported reduced peripheral blood DNA-methylation
which was only partially reversible after smoking cessa-
tion [48]. In addition, pet keeping and tobacco smoke
exposure was shown to limit increase in CD14 methyla-
tion from 2 to 10 years of age in 157 children from the
prospective Environment and Childhood Asthma birth
cohort, partly explaining the diverging CD14 allele asso-
ciations with allergic diseases detected in different envi-
ronments [49].
With regard to asthma, genome-wide DNA methyla-
tion of CpG sites was recently assessed in peripheral
blood leukocytes from 245 female participants of the Isle
of Wight cohort at the age of 18 years [50]. In a subset
of 16 and 18 women with and without asthma, DNA
methylation was assessed in samples collected at 10 years
of age. Focussing on genes of the Th2 pathway (IL4,
IL4R, IL13, GATA3, STAT6), the authors demonstrated
that the odds of asthma tended to decrease at the age of
10 years with increasing GATA3 methylation. This effect
disappeared by age 18. Depending on the IL-4R geno-
type, methylation of two CpG sites was associated with
higher risk of asthma in 18 year olds. These CpGs had
no effect at the age of 10 years. Increasing methylation
of one of the CpGs over time was related to a reduced
risk of developing asthma in the first 10 years of life and
increased the probability for 10-year-old asthmatics to
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shows not only an interaction between IL-4R gene vari-
ants and DNA methylation in relation to asthma but
also an effect of temporal change of DNA methylation
on asthma transition between ages 10 and 18.
Prenatal exposures and epigenetic changes related to
asthma or COPD risk
Numerous prenatal exposures such as maternal asthma
or atopy, maternal nutrition or obesity during pregnancy,
maternal gestational stress, and pollutants have been
brought into context with respiratory disease. Among
these, maternal smoking during pregnancy is one of the
most important risk factors for impaired lung function
development and asthma risk [51-53]. Since childhood
asthma was shown to increase the risk for adult airflow
obstruction by 20-fold [54], prenatal smoke exposure is
also a potential risk factor for COPD.
Maternal smoking has been linked with genome-wide
higher methylation of peripheral blood. In 92 adult
women from a birth cohort dating back to 1959 (New
York participants of the ‘National Collaborative Perinatal
Project’) methylation of repetitive elements (LINE1-M1,
Sat2-M1, Alu-M2), which are markers of global methyla-
tion in the identical blood samples, showed an inverse
association between prenatal smoke exposure and Sat2
methylation [55]. In addition, an inverse dose-response re-
lationship was observed between cord blood cotinine
levels and global cord blood DNA hypomethylation in 30
newborns [56].
Breton et al. observed lower DNA methylation levels
of the short interspersed nucleotide element AluYb8 in
buccal cells from 348 prenatally exposed kindergarten
and elementary school children [57]. Hypomethylation
of LINE-1 was only seen in prenatally exposed children
who were glutathione S-transferase (GST) M1 null,
while methylation was higher in those with GSTM1.
Thus, variants in detoxification genes may modulate the
effects of prenatal exposure via differential epigenetic
marks.
In candidate gene approaches, significant, albeit small
differences in methylation of Neuropeptide S Receptor 1
(NPSR1) were observed in whole blood samples from
adults with severe asthma and children with physician-
diagnosed allergic asthma of a Swedish Birth cohort
(BAMSE). In children, the NPSR1 methylation status
was influenced by prenatal smoke exposure [58]. Pre-
natal smoke exposure throughout pregnancy was further
associated with higher DNA methylation of the pater-
nally expressed insulin-like growth factor 2 (IGF2) in
cord blood when compared to samples from infants
born to mothers who quit smoking in early pregnancy.
There was a clear gender difference as methylation levels
differed most significantly in male offspring [59].Within the Isle of Wight birth cohort, Patil et al.
analyzed the interaction of six CpG sites in the IL-13
promoter with two functional gene variants of IL-13 in
245 female participants at the age of 18 years. The au-
thors demonstrated a) an interaction of one functional
IL-13 gene variant, rs20541, and maternal smoking dur-
ing pregnancy with DNA methylation at one CpG site
and b) that the interaction of this CpG site with another
functional SNP affected airflow limitation and airway re-
activity [2]. The authors propose a two-stage model
where exposures first interact with so called methylation
quantitative trait loci, that is, gene variants affecting sus-
ceptibility to DNA methylation, thereby modifying gene
regulation. The response to subsequent environmental
challenges potentially interacting with other gene vari-
ants within the same gene in a second stage would then
be affected by the presence or absence of the epigenetic
modification established during the first stage.
In an epigenome-wide association study (EWAS),
lower cord blood DNA methylation of cytochrome
P450 aryl-hydrocarbon-hydroxylase (CYP1A1) gene and
hypermethylation of most investigated CpG sites of the
aryl hydrocarbon receptor repressor gene (AHRR) were
demonstrated in 1,062 prenatally smoke-exposed children
of the Norwegian Mother and Child Cohort Study (MoBa)
[45]. Both molecules play an important role in metaboliz-
ing xenobiotics and were also modified in adult smokers
[60]. Thus, prenatal tobacco smoke exposure may predis-
pose to altered responses towards xenobiotics in later life
via lasting epigenetic modifications which could affect the
risk for pulmonary disease. In contrast to the findings in
cord blood, the identical CYP1A1 CpG sites were hypo-
methylated in placentae of smoking women with higher
CYP1A1 mRNA expression [61]. Further changes of glo-
bal DNA methylation in placental tissue from smoking
mothers have been reported [62,63].
Another recent large EWAS identified and partly
newly confirmed 185 CpG sites with altered methylation
among FRMD4A, ATP9A, GALNT2, and MEG3, in
whole blood of infants of smokers within 889 newborns
from the Norway Facial Clefts Study.
These genes are implicated in processes related to
nicotine dependence, smoking cessation, and placental
and embryonic development [64]. In addition to blood
sample analyses, recently, an EWAS was performed in
85 fetal lung and the corresponding placental tissue sam-
ples of which 41 were smoke exposed, using the Illumina
HumanMethylation450 BeadChip array. Analyses of DNA
methylation was conducted to evaluate the variation asso-
ciated with nicotine exposure. The most significant differ-
entially methylated CpG sites in the fetal lung analysis
mapped to the PKP3, ANKRD33B, CNTD2, and DPP10
genes. In the placental methylome, however, the most
significant CpG sites mapped to the GTF2H2C and
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ant between lung and placental tissue analyses. Gene Set
Enrichment Analysis demonstrated enrichment of specific
disorders, such as asthma and immune disorders, suggest-
ing a role for DNA methylation variation in the fetal ori-
gins of chronic diseases [65].
Besides maternal smoking, prenatal exposure to air-
borne pollutants has been suggested as risk factor for
asthma. High prenatal exposure to polycyclic aromatic
hydrocarbons (PAH) has been reported to be associated
with higher methylation of an enzyme involved in fatty
acid metabolism termed acyl-CoA synthetase long-chain
family member 3 (ACSL3) in cord blood DNA and
matched fetal placental tissues [66]. The relation of
ACSL3 function with asthma is not known. In a subse-
quent study, the authors reported hypermethylation of the
IFNγ promoter in cord blood DNA in association with
maternal PAH exposure [67]. Higher levels of prenatal
dichlorodiphenyldichloroethylene, a metabolite from the
pesticide DDT, were associated with DNA hypomethyla-
tion at age 4 years of a CpG site in the arachidonate 12-
lipoxygenase (ALOX12) gene and associated with persist-
ent wheezing in 6-year-old children from two independent
Spanish cohorts. ALOX12 DNA methylation was further
associated with genetic polymorphisms [68].
Intrauterine exposure to a farming environment has
further been associated with decreased risk for asthma
and allergies. The CD14 promoter region was differently
methylated in placentae from women living on a farm
compared to non-farming women [69].
In a birth cohort, cord blood Treg cell counts were in-
creased with maternal farming exposures during preg-
nancy and associated with higher FOXP3 expression
[70]. FOXP3 hypomethylation was increased with mater-
nal consumption of farm milk. More recently, the Pro-
tection against allergy: study in rural environments
(PASTURE) study was used to investigate methylation
patterns of ten asthma candidate genes in cord blood
and at age 4.5 years. ORMDL1 and STAT6 were hypo-
methylated in cord blood DNA from farmers’ offspring,
while regions in RAD50 and IL-13 were hypermethy-
lated [71]. An association with asthma was only seen in
non-farming offspring for hypermethylated cord blood
ORMDL3 and STAT6. Irrespective of the exposure or
disease status, methylation of several asthma and allergy-
related genes changed over time (IL-4, IL-13, ORMDL3,
RAD50), indicating their involvement in developmental
processes, while Treg-related genes (FOXP3, RUNX3)
remained unchanged.
Exposures beyond the mother: what about fathers and
ancestors?
Studies based on historical records of a small population
in North Sweden (Överkalix) reported that the mortalityrate of men is linked to food supply of the father’s father
in mid-childhood, while the mortality rate of women
was exclusively related to food supply of their father’s
mother [72]. Data from the Avon Longitudinal Study of
Parents and Children (ALSPAC) indicate an association
of grandmaternal smoking with increased birth weight,
birth length, and BMI in grandsons of non-smoking
mothers but not in granddaughters. The same group of
authors reported an association of paternal prepubertal
smoking with greater BMI of their sons [73].
To date, there is very limited evidence for an exclusive
establishment of risk for respiratory disease via the
mother. Li et al. reported in 2005 that a grandchild’s
asthma risk is increased if the grandmother smoked cig-
arettes during her pregnancy, even if the mother did not
smoke [74]. So far, this issue has been investigated again
in the ALSPAC where such an association was seen for
the paternal, but not the maternal, grandmother [75].
Interestingly, this relation was stronger for granddaugh-
ter than for grandson’s asthma risk indicating again
gender-specific effects. Epigenetic alterations were not
investigated in these studies. Also in the Norwegian
Mother and Child Cohort Study, grandmother’s smoking
when pregnant with the mother was not associated with
cord blood DNA methylation in the grandchild at loci
associated with maternal smoking during pregnancy
[76]. This however, does not exclude the possibility that
the grandmother’s smoking is associated with DNA
methylation in the grandchild in other areas of the
genome.
Experimental intergenerational epigenetics
Animal models facilitate to investigate epigenetic inherit-
ance across generations. So far, a number of prenatal
exposure scenarios including maternal exposure to aller-
gens [77], tobacco [78], nicotine [79,80], pollutants [81],
bacteria or bacterial compounds [82], fungi [83], and
maternal stress [84] have been investigated in intergen-
erational animal models for asthma risk (Table 1).
Several studies report reduced lung function [78,84-87]
and/or altered lung structure [78,87-89]. In addition,
expression of genes with known or so far unknown rela-
tionship to asthma was investigated [90,91]. However,
there is currently a paucity of studies aiming to investigate
underlying epigenetic mechanisms [80,92]. Although sev-
eral models included exposures during the preconcep-
tional period [77,93-97], very few addressed effects on
asthma risk during this period only [93,98].
Up to date, several intergenerational animal models
exist which address fetal exposure to maternal passive
smoking [85]. A study by Rouse et al. reported that in
utero exposure to environmental tobacco smoke (ETS)
did not alter the respiratory structure or function in
offspring at the age of 10 weeks [91]. However, after
Table 1 Overview of experimental in utero exposure models
Exposure type Preconceptional exposure Prenatal exposure Postnatal challenge
Sidestream tobacco smoking
(SS; ‘passive smoking’)




MS [78,86,90,102,103,134,135] MS [78,86,90,101-103,134,135] SS [86,134], A. fumigates [86],
HDM [78], MS [103,135]
Active and passive tobacco
smoking
MS + SS vs. SS [136]
Surrogate for tobacco smoking Nicotine [137], nicotine (F1*)
[9,80]
Nicotine [79,138-142], nicotine (F1) [9,80] Nicotine [79], nicotine
(F1*) [9,80]
Pollutants BPA [143], TDI or DNCB [144] BPA [143,145,146], DEP [147-149] DEP,
TiO2, or carbon black [150], ROFA [151],
ozone [152], UPM [153], FA [154]
OVA [143,144,147,150,152-154],
low- or
high-fat diet [148], ozone [149]
Allergens OVA [77,93,96,97,105,155-157],
peanut [92]
OVA [77,96,155,158-160], OVA + Al(OH)3
OVA + PT, or OVA + CpG [161]
OVA [77,93,96,105,156-160], OVA or
Casein [155], OVA or BLG [97],
OVA + Al(OH)3 [161], peanut [92]
Bacteria and bacterial
compounds
LPS [82] LPS [82,162,163], LPS + iNOS inhibitor [164],
A. lwoffii F78 [165,166], L. rhamnosus [167]
OVA [82,163-167], LPS, or
OVA [162]
Fungi A. fumigates [83,108],
M. anisopliae [168]









Noise [169], methyl donor supplement [109],
vitamin A-deficient diet [171], vitamin
D3-deficient diet [170], vitamin D-deficient
diet [172], FBZ [173]
OVA [109,169], vitamin D3-deficient
diet [170], vitamin D-deficient diet
FBZ [172] and OVA [173]
Studies investigating effects up to F2: [80,83,109]. Studies investigating effects up to F3: [9,145]. Studies using rhesus monkeys: [126] (all other studies mentioned
use rodents). Not all studies relate to a lung phenotype. *Studies with F1 animals exposed via mothers milk and used for further breeding. OVA, ovalbumin; HDM,
house dust mite extract; BPA, bisphenol A; TDI, toluol-2,4-diisocyanat; DNCB, dinitrochlorobenzene; DEP, diesel exhaust particles; ROFA, residual oil fly ash; UPM,
urban particulate matter; FA, formaldehyde; PT, pertussis toxin; BLG, beta-lactoglobulin; LPS, lipopolysaccharide; FBZ, fenbendazol.
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age of 10 weeks, lung function was impaired in both
male and female offspring. Microarray analysis, only
performed in lungs from female offspring, revealed a
number of downregulated genes. Those are related to
asthma and immune responses and include CCL8,
CCL11, CCL24, IL4, IL6, IL10, IL13, IL1β, TNFą, and
others. In a similar second hit scenario, dams were ex-
posed to ETS from 2 weeks prior to conception until
weaning of the pups. Airway reactivity was moderately
increased in exposed offspring at baseline but in-
creased dramatically together with Th2 cytokines and
IgE after repeated intratracheal Aspergillus (A.) fumi-
gatus instillation as compared to non-exposed con-
trols. BHR, but not allergic sensitization, was mediated
by increased expression of M1, M2, and M3 muscarinic
receptors and the phosphodiesterase-4D5 isozyme as
shown in inhibitor experiments [99].
Upregulation of Th2 cytokines and molecules along
the Th2 pathway was further confirmed in another set of
experiments with prolonged postnatal ETS exposure
followed by repeated intratracheal A. fumigatus chal-
lenges. In contrast, goblet cell metaplasia and the ex-
pression of mucus-related genes were downregulated.
The authors propose that prenatal ETS may alter the
ability of mucociliary clearance [87]. In another study, pre-
natal ETS exposure followed by postnatal re-exposure wasassociated with impaired lung function, elevated pro-
inflammatory cytokines in BALF and with morphological
changes of the lungs. Here, the mRNA levels of metallo-
proteases ADAMST9 and MMP3 were upregulated,
suggesting a profibrotic milieu with predisposition for ob-
structive pulmonary disease [100].
In an animal model for active smoking, similar to the
human situation, active smoking during second and
third trimester of pregnancy negatively affected birth
weight and lung volume in murine offspring [101]. In
addition, Singh et al. showed, in animals prenatally
exposed to active maternal smoke exposure, BHR devel-
opment following postnatal exposure to a single intratra-
cheal injection of A. fumigatus extract in early adulthood.
Interestingly, the increased BHR was not associated with
more leukocyte migration or mucus production in the
lung but was causally related to lower lung cyclic adeno-
sine monophosphate levels, modulated by increased
phosphodiesterase-4 enzymatic activity in the lung [86].
However, increased BHR was related to airway inflamma-
tion or mucus production in a different (ETS) model for
maternal smoke exposure, investigated by the same re-
search group [87].
In children, Haley et al. [102] investigated the effect of
intrauterine smoke exposure on the expression of runt-
related transcription factors (RUNX)1-3 which have crit-
ical roles in immune system development and function.
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ated with BHR in asthmatic children and this associ-
ation was hypothesized to be modified by intrauterine
smoke exposure. Indeed, 17 out of 100 RUNX1 single-
nucleotide polymorphisms (SNPs) were significantly
associated with methacholine responsiveness, and the
association with one of the SNPs was significantly
modified by a history of intrauterine smoke exposure.
Quantitative PCR analysis of immature human lung
tissue suggested an increased expression of RUNX at
the pseudoglandular stage of lung development after
intrauterine smoke exposure. The intrauterine smoke
effect on RUNX expression was further investigated in
a mouse model. In this model, intrauterine smoke ex-
posure additionally altered RUNX expression in lung
tissue samples at postnatal days (P)3 and P5, in the al-
veolar stage of lung development. In an additional
mouse study from this group, abnormal alveolariza-
tion, induced by intrauterine smoke exposure, was fur-
ther associated with altered retinoic acid pathway
element expression in the offspring [103]. Disrupted
RUNX expression and retinoic acid signaling could
therefore partly explain the consistent identification of
maternal smoking as a risk factor for pediatric asthma.
Data from our own lab also indicate an effect of
maternal smoking on gene transcription and lung devel-
opment. Blacquiére et al. demonstrated that active
smoking from 3 weeks prior to conception until birth re-
sulted in lower expression of encoding forkhead box a2
(FOXA2), frizzled receptor 7 (FZD-7), epidermal growth
factor (EGF), β-catenin (CTNNB1), fibronectin (FN1),
and platelet-derived growth factor receptor alpha
(PDGFRą) in neonatal offspring [90]. These genes are
members of, or related to, the Wnt/β-catenin pathway,
which plays an important role in lung branching
morphogenesis [104]. In addition, in adult non-
smoking F1 progeny from these smoking mothers, in-
creased deposition of collagen III and smooth muscle
layer thickening around the airways was found [78].
These characteristics of lung remodeling are typical for
obstructive lung diseases such as asthma and COPD.
The observed lung remodeling was associated with an
increase in methacholine responsiveness, which is a
risk factor for accelerated lung function decline in the
general population and development of COPD. Since
these striking differences were observed in adult mice
that were not exposed to cigarette smoke after birth, it
suggests that persistent smoke-induced epigenetic changes
occurred in embryonic lungs during pregnancy.
Numerous studies investigated the effect of maternal
sensitization and/or asthma phenotype in the offspring
[96,105-107]. In some instances, combinations of aller-
gen and pollutants were used [108]. Fedulov et al. dem-
onstrated in 2011 that adoptive transfer of dendritic cells(DCs) from allergen-naive neonates from asthmatic
mothers into 3-day-old mice from non-asthmatic
mothers conferred increased allergen responsiveness
resulting in heightened BHR and allergic inflammation.
While the phenotype of ‘asthma-susceptible’ DCs was
largely unaltered, DCs showed enhanced allergen-
presentation activity in vitro and a global increase in
DNA methylation. The ‘asthma-transferring’ ability
seemed to be restricted to DCs, as other investigated
immune cell types did not show this ability [93]. In a
model of maternal peanut food allergy, offspring exhib-
ited higher peanut-specific IgE and histamine levels
with more severe anaphylaxis after suboptimal oral
peanut challenge compared to prenatally non-exposed
offspring [92]. Pyrosequencing revealed hypomethylated
IL-4 CpG sites in splenocytes and DNA methylation levels
correlated inversely with IgE levels.
Experimental transgenerational epigenetics
Evidence for transgenerational transmission of asthma
risk beyond the F1 generation was demonstrated by
Hollingsworth et al. who were the first to describe the
effect of dietary methyl donors on the risk for allergic
airway disease via epigenetic mechanisms [109]. In this
work, methyl supplementation of pregnant and weaning
dams increased the severity of allergic airway disease in
the offspring but not in the mothers. There was a less
prominent effect on airway eosinophilic inflammation
and IgE-level in the F2 generation, and this effect was
transmitted paternally. The modified risk was associated
with altered DNA methylation of several genes including
RUNX3, in phenotypic extremes of the F1 progeny. As
mentioned earlier, RUNX3 is known to regulate T cell
development and to downregulate airway eosinophilia.
Nonetheless, work in mice indicates that the risk of aller-
gic airway disease can a) be modified through epigenetic
mechanisms and b) during vulnerable developmental
periods only. Preconceptional exposure to intranasal A.
fumigates, in early vs late pregnancy, resulted in lower IgE
in grand-offspring who were re-exposed in young adult-
hood [83]. BALF eosinophils were increased or decreased
depending on the timing of allergen exposure during preg-
nancy of the grandmothers. Pyrosequencing of lung DNA
showed hypomethylated IL-4 CpG sites after early A.
fumigatus exposure, whereas IFNγ was hypomethylated
independent of the timing of exposure. The results from
the epigenetic studies do not accord very well with the
data on airway eosinophilia. However, the work demon-
strates again that maternal exposures can affect the sec-
ond generation and that the effects may depend from the
timing of exposure during pregnancy.
Truly transgenerational transmission of the asthma
phenotype to F3 offspring was shown in a rat model of
perinatal nicotine exposure [9]. The F3 generation
Krauss-Etschmann et al. Clinical Epigenetics  (2015) 7:53 Page 8 of 13corresponds to the great-grandchildren and is thus the
first generation to be totally unexposed to the original
agent. In this model, exposure of F0 dams resulted in
abnormal pulmonary function, as well as altered ex-
pression of the remodeling marker fibronectin in F3.
Interestingly, this transgenerational effect was sex-specific
occurring exclusively in males. In the F2 generation, global
DNA methylation was increased in the testes, but de-
creased in the ovaries, and was not changed in the lungs.
H3 acetylation was increased in the lungs and testes, and
H4 acetylation decreased in the lungs while it increased in
the testes and ovaries, suggesting that epigenetic informa-
tion predisposing to asthma may be transmitted through
the germ line in this model. However, it remains unclear
whether the transgenerational effect is being carried
through the male or female germ line.
Potential mechanisms leading to transgenerational
inheritance
Reprogramming of the epigenome A major barrier to
transgenerational inheritance is developmental repro-
gramming. During this process, DNA methylation, his-
tone variants and their modifications, as well as small
RNAs are all reset. This is required to remove epigenetic
signatures acquired during development or imposed by
the environment. It enables the zygote to acquire the
totipotent state needed for the differentiation into all cell
types. In mice, there are at least two rounds of genome-
wide DNA methylation reprogramming. The first occurs
just after fertilization, in the zygote and early cleavage
stages, to erase gametic (sperm and oocyte) epigenomic
marks. The next major reprogramming process occurs
in the cells that will form the germ line of the develop-
ing embryo to achieve an epigenetic state distinct from
somatic cells. In each reprogramming window, a specific
set of mechanisms regulates erasure and re-establishment
of DNA methylation [13,14]. Still, there is strong evidence
for persisting transmission of the DNA methylation
through the gametes to the next generation at a small
number of loci in the mouse [110]. In a study investigating
DNA methylation during early development of the mouse
embryonic lineage in vivo, analysis of around 1,000 CpG
islands (CGIs) within ovulated eggs showed that 15% are
methylated [111]. The level of methylation was higher
(25%) in sperm but the proportion of individual CpG sites
methylated in CGIs in sperm was lower. By the blastocyst
stage many of these methylated CGIs show some loss of
methylation but not to the very low levels predicted by
the accepted model for epigenetic reprogramming
[112]. These were non-imprinted, non-repetitive genes
(retrotransposons).
Parental imprinting Parental imprinting, also known as
genomic imprinting, is the process by which genes areexpressed on only one of the two parental inherited
chromosomes (either from the mother or father). During
gamete formation, following germ line reprogramming
where the paternal and maternal somatic programs are
erased, parent-specific imprints are laid down in the
germ line by epigenetic mechanisms [11,113]. Imprinting
is displayed in only a few hundred genes in the human
genome, of which most of them are located in clusters
that are regulated through the use of insulators or long
non-coding RNAs. However, as the imprint or memory
lasts one generation, parental imprinting is not considered
to be an example of transgenerational inheritance [10].
Chromatin proteins and epigenetic inheritance Dur-
ing mammalian spermatogenesis, chromatin in differen-
tiating germ cells is extensively remodeled, with the
majority of nucleosomes being removed and ultimately
exchanged by highly basic proteins named protamines.
The remaining nucleosomes, unlike protamines that are
exclusively re-replaced by maternal nucleosomes in the
zygotes, may potentially direct certain processes of de-
velopment and are thus a potential source for epigenetic
inheritance through the paternal germ line [114]. There-
fore, the genomic loci associated with retained nucleo-
somes in sperm are of great interest and have been
investigated by several groups [115-118]. This has recently
led to some debate on the genome-wide localization of
these nucleosomes and their modification and/or variant
states [119]. Two independent studies provided evidence
that in mammalian sperm, nucleosomes are retained
predominantly within distal gene poor regions and are
depleted significantly in promoters of genes for devel-
opmental regulators [117,118]. However, these obser-
vations contradict a previous report that the retained
nucleosomes in human sperm are significantly
enriched at loci of developmental importance, includ-
ing imprinted gene clusters, microRNA clusters, and
HOX gene clusters [116]. More precise knowledge of
the genome-wide distribution of the nucleosomes
retained in mammalian spermatozoa is important to
clarify their functional significance.
MicroRNAs and epigenetic inheritance Non-protein
coding RNAs (ncRNAs) are RNA sequences that regu-
late transcriptional and/or translational processes. Of the
species of ncRNAs, the four best-characterized forms are
microRNAs (miRNAs), small interfering RNAs (siRNAs),
Piwi-interacting RNAs (piRNAs), and long non-coding
RNAs (long ncRNAs) [120]. miRNAs are a distinct class
of ncRNAs and differ from other species of ncRNAs in
both how they are formed as well as their particular mech-
anism of action. miRNAs are processed from precursor
transcripts which fold back on themselves, forming hair-
pin structures [121]. In general, miRNAs bind to mRNAs
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repression. Expression of miRNAs is controlled by
DNA methylation of promoter-associated CpG sites of
miRNA genes, as well as post-translational histone
modifications [122].
Human spermatozoa are known to contain a large
range of RNA molecules, including over 100 miRNAs
[5,120,123,124]. Interestingly, in the spermatozoa of
smokers, a total of 28 known human miRNAs were
significantly differentially expressed compared with non-
smokers. Ten out of the twenty-eight miRNAs had
validated targets. These altered miRNAs predominantly
mediated pathways vital for healthy sperm and normal
embryo development, particularly cell death and apop-
tosis. Of interest is that in addition, 25 components of
the epigenetic machinery (different modulators of DNA
methylation and histone modification, such as DNMT3A,
DNMT3B, and several HDACs) were shown to be targets
of the altered miRNAs [5]. This means that these miRNAs
could act as potential epi-miRNAs by mediating changes
in DNA methylation and/or histone modification. In this
way, miRNAs could affect phenotypes in future progeny.
Also in oocytes (mouse), different classes of ncRNAs
have been described [125].
Conclusions
Although a number of human studies have reported an
association of prenatal smoke exposures with epigenetic
changes in relation to asthma and COPD, there is very
few human data available regarding the effect of grand-
parental exposures on disease risk in grandchildren and
even less with information on epigenetic events. In
addition, all available epidemiological studies address in-
tergenerational rather than true transgenerational propa-
gation of risk for respiratory disease. Although the few
data from experimental animal models show evidence
for transgenerational inheritance, also for early nutri-
tional environmental exposures, further investigations in
these models are clearly needed to unravel the under-
lying mechanisms. Moreover, large, well-characterized
cohort studies would be needed to explore whether
transgenerational inheritance indeed also occurs in
humans. It will be important to investigate epigenetic
signatures over time in birth cohorts and, where pos-
sible, across generations and to validate them in inde-
pendent cohorts. Other important knowledge gaps that
need to be addressed in the future are the need to
understand the functional consequences of differen-
tially methylated genes: even though some studies can
associate subtle changes with phenotype, these may
still represent an epiphenomenon. On the other hand,
small changes could be important when multiple genes
along a given pathway are affected. Also, epigenetic
regulation is likely to differ in men and women, butthis gender-specific difference has received little atten-
tion so far. In this respect, animal models can facilitate
inter- and transgenerational research and may allow
preclinical testing of interventions preventing devi-
ation of epigenetic signatures to interrupt propagation
of disease risks.
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